• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国高发和低发侵袭性脑膜炎奈瑟菌病时期的脑膜炎奈瑟菌携带情况:英国脑膜炎奈瑟菌携带 1-4 项横断面调查结果比较。

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results.

机构信息

Department of Zoology, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.

Meningococcal Reference Unit, Public Health England, Manchester Public Health Laboratory, Manchester Royal Infirmary, Manchester, UK.

出版信息

Lancet Infect Dis. 2021 May;21(5):677-687. doi: 10.1016/S1473-3099(20)30842-2. Epub 2021 Jan 19.

DOI:10.1016/S1473-3099(20)30842-2
PMID:
33482143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064914/
Abstract

BACKGROUND

The incidence of invasive meningococcal disease in the UK decreased by approximately four times from 1999 to 2014, with reductions in serogroup C and serogroup B disease. Lower serogroup C invasive meningococcal disease incidence was attributable to implementation of the meningococcal serogroup C conjugate vaccine in 1999, through direct and indirect protection, but no vaccine was implemented against serogroup B disease. UK Meningococcal Carriage surveys 1-3 (UKMenCar1-3), conducted in 1999, 2000, and 2001, were essential for understanding the impact of vaccination. To investigate the decline in invasive meningococcal disease incidence, we did a large oropharyngeal carriage survey in 2014-15, immediately before the changes to meningococcal vaccines in the UK national immunisation schedule.

METHODS

UKMenCar4 was a cross-sectional survey in adolescents aged 15-19 years who were enrolled from schools and colleges geographically local to one of 11 UK sampling centres between Sept 1, 2014, and March 30, 2015. Participants provided an oropharyngeal swab sample and completed a questionnaire on risk factors for carriage, including social behaviours. Samples were cultured for putative Neisseria spp, which were characterised with serogrouping and whole-genome sequencing. Data from this study were compared with the results from the UKMenCar1-3 surveys (1999-2001).

FINDINGS

From the 19 641 participants (11 332 female, 8242 male, 67 not stated) in UKMenCar4 with culturable swabs and completed risk-factor questionnaires, 1420 meningococci were isolated, with a carriage prevalence of 7·23% (95% CI 6·88-7·60). Carriage prevalence was substantially lower in UKMenCar4 than in the previous surveys: carriage prevalence was 16·6% (95% CI 15·89-17·22; 2306/13 901) in UKMenCar1 (1999), 17·6% (17·05-18·22; 2873/16 295) in UKMenCar2 (2000), and 18·7% (18·12-19·27; 3283/17 569) in UKMenCar3 (2001). Carriage prevalence was lower for all serogroups in UKMenCar4 than in UKMenCar1-3, except for serogroup Y, which was unchanged. The prevalence of carriage-promoting social behaviours decreased from 1999 to 2014-15, with individuals reporting regular cigarette smoking decreasing from 2932 (21·5%) of 13 650 to 2202 (11·2%) of 19 641, kissing in the past week from 6127 (44·8%) of 13 679 to 7320 (37·3%) of 19 641, and attendance at pubs and nightclubs in the past week from 8436 (62·1%) of 13 594 to 7662 (39·0%) of 19 641 (all p<0·0001).

INTERPRETATION

We show that meningococcal carriage prevalence in adolescents sampled nationally during a low incidence period (2014-15) was less than half of that in an equivalent population during a high incidence period (1999-2001). Disease and carriage caused by serogroup C was well controlled by ongoing vaccination. The prevalence of behaviours associated with carriage declined, suggesting that public health policies aimed at influencing behaviour might have further reduced disease.

FUNDING

Wellcome Trust, UK Department of Health, and National Institute for Health Research.

摘要

背景

自 1999 年至 2014 年,英国侵袭性脑膜炎球菌病的发病率降低了约四倍,其中 C 群和 B 群疾病的发病率降低。C 群侵袭性脑膜炎球菌病发病率降低归因于 1999 年实施了脑膜炎球菌 C 群结合疫苗,通过直接和间接保护,但没有针对 B 群疾病实施疫苗。英国脑膜炎球菌带菌调查 1-3 项(UKMenCar1-3)于 1999 年、2000 年和 2001 年进行,对于了解疫苗接种的影响至关重要。为了调查侵袭性脑膜炎球菌病发病率的下降,我们在 2014-15 年进行了一项大规模的口咽带菌调查,这是在英国国家免疫计划改变脑膜炎球菌疫苗之前进行的。

方法

UKMenCar4 是一项在年龄在 15-19 岁的青少年中进行的横断面调查,这些青少年从 11 个英国采样中心之一所在地区的学校和学院招募。参与者提供口咽拭子样本,并完成了一份关于带菌风险因素的问卷,包括社交行为。对样本进行了可能的奈瑟氏菌属的培养,并用血清群分型和全基因组测序进行了特征分析。本研究的数据与 UKMenCar1-3 调查(1999-2001 年)的结果进行了比较。

结果

在 UKMenCar4 中,有 19641 名有可培养拭子和完成风险因素问卷的参与者(11332 名女性,8242 名男性,67 名未说明),分离出 1420 株脑膜炎球菌,带菌率为 7.23%(95%CI 6.88-7.60)。带菌率明显低于之前的调查:UKMenCar1(1999 年)中带菌率为 16.6%(95%CI 15.89-17.22;13901/13650),UKMenCar2(2000 年)中带菌率为 17.6%(17.05-18.22;16295/16295),UKMenCar3(2001 年)中带菌率为 18.7%(18.12-19.27;17569/17649)。除 Y 群外,UKMenCar4 中所有血清群的带菌率均低于 UKMenCar1-3,Y 群的带菌率不变。促进带菌的社交行为的流行率从 1999 年到 2014-15 年下降,报告定期吸烟的个体从 13650 人中的 2932 人(21.5%)下降到 19641 人中的 2202 人(11.2%),过去一周亲吻的人数从 13679 人中的 6127 人(44.8%)下降到 19641 人中的 7320 人(37.3%),过去一周参加酒吧和夜总会的人数从 13594 人中的 8436 人(62.1%)下降到 19641 人中的 7662 人(39.0%)(均 p<0.0001)。

解释

我们表明,在低发病率期间(2014-15 年)全国范围内抽样的青少年中,脑膜炎球菌带菌率不到高发病率期间(1999-2001 年)的一半。血清群 C 引起的疾病和带菌得到了持续疫苗接种的很好控制。与带菌相关的行为的流行率下降,表明旨在影响行为的公共卫生政策可能进一步降低了疾病的发病率。

资助

威康信托基金会、英国卫生部和英国国家卫生研究院。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/7f67fd15757a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/d252a7836a2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/ba50db945e27/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/1afff9a45ad7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/19879011469f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/7f67fd15757a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/d252a7836a2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/ba50db945e27/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/1afff9a45ad7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/19879011469f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6445/8064914/7f67fd15757a/gr5.jpg

相似文献

1
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results.英国高发和低发侵袭性脑膜炎奈瑟菌病时期的脑膜炎奈瑟菌携带情况:英国脑膜炎奈瑟菌携带 1-4 项横断面调查结果比较。
Lancet Infect Dis. 2021 May;21(5):677-687. doi: 10.1016/S1473-3099(20)30842-2. Epub 2021 Jan 19.
2
'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.“加入团队”研究(青少年抗击脑膜炎):一项评估4CMenB或MenB-fHbp疫苗接种对青少年脑膜炎球菌咽部携带情况影响的对照临床试验方案
BMJ Open. 2020 Oct 22;10(10):e037358. doi: 10.1136/bmjopen-2020-037358.
3
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.脑膜炎奈瑟菌 ACWY 结合疫苗对青少年咽拭子携带的影响:来自英国 MenACWY 计划的群体保护证据。
Clin Microbiol Infect. 2022 Dec;28(12):1649.e1-1649.e8. doi: 10.1016/j.cmi.2022.07.004. Epub 2022 Jul 13.
4
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.在澳大利亚,青少年中的 B 型脑膜炎球菌疫苗和脑膜炎球菌带菌情况。
N Engl J Med. 2020 Jan 23;382(4):318-327. doi: 10.1056/NEJMoa1900236.
5
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.四价脑膜炎奈瑟菌 ACWY 荚膜多糖结合疫苗或 B 型脑膜炎奈瑟菌疫苗对脑膜炎奈瑟菌带菌的影响:一项观察者盲、3 期随机临床试验。
Lancet. 2014 Dec 13;384(9960):2123-31. doi: 10.1016/S0140-6736(14)60842-4. Epub 2014 Aug 18.
6
Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study.意大利托斯卡纳地区 C 群脑膜炎奈瑟菌血清型 11(cc11)引起的侵袭性脑膜炎球菌病爆发期间的带菌率和危险因素:一项横断面研究。
BMC Infect Dis. 2019 Jan 8;19(1):29. doi: 10.1186/s12879-018-3598-3.
7
Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.巴西萨尔瓦多大规模脑膜炎球菌C结合疫苗接种运动后青少年中的脑膜炎球菌携带情况。
PLoS One. 2016 Nov 18;11(11):e0166475. doi: 10.1371/journal.pone.0166475. eCollection 2016.
8
Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys.在布基纳法索引入A群脑膜炎球菌结合疫苗7年后的脑膜炎球菌携带情况:四项横断面携带情况调查结果
Lancet Infect Dis. 2020 Dec;20(12):1418-1425. doi: 10.1016/S1473-3099(20)30239-5. Epub 2020 Jul 9.
9
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.脑膜炎球菌C群结合疫苗对带菌状态和群体免疫的影响。
J Infect Dis. 2008 Mar 1;197(5):737-43. doi: 10.1086/527401.
10
Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.2015 - 2016年罗德岛一所大学针对B群脑膜炎球菌病暴发及大规模疫苗接种运动开展的脑膜炎球菌携带情况评估
Clin Infect Dis. 2017 Apr 15;64(8):1115-1122. doi: 10.1093/cid/cix091.

引用本文的文献

1
A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvements.一项关于荷兰国家免疫规划的文献综述及基于证据的评估揭示了改进的可能性。
Vaccine X. 2024 Sep 26;20:100556. doi: 10.1016/j.jvacx.2024.100556. eCollection 2024 Oct.
2
Diverse proinflammatory response in pharyngeal epithelial cells upon interaction with Neisseria meningitidis carriage and invasive isolates.咽上皮细胞与脑膜炎奈瑟菌带菌株和侵袭性分离株相互作用时表现出不同的促炎反应。
BMC Infect Dis. 2024 Mar 6;24(1):286. doi: 10.1186/s12879-024-09186-3.
3
Geographical distribution of invasive meningococcal disease and carriage: A spatial analysis.

本文引用的文献

1
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.在澳大利亚,青少年中的 B 型脑膜炎球菌疫苗和脑膜炎球菌带菌情况。
N Engl J Med. 2020 Jan 23;382(4):318-327. doi: 10.1056/NEJMoa1900236.
2
UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence.英国男性青少年脑膜炎球菌携带情况4:在侵袭性脑膜炎球菌病发病率较低时期对英国青少年无症状脑膜炎球菌携带情况的横断面调查。
Wellcome Open Res. 2019 Oct 28;4:118. doi: 10.12688/wellcomeopenres.15362.2. eCollection 2019.
3
Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review.
侵袭性脑膜炎奈瑟菌病和带菌者的地理分布:空间分析。
Epidemiol Infect. 2024 Jan 18;152:e22. doi: 10.1017/S0950268824000116.
4
Molecular characteristics of Neisseria meningitidis carriage strains in university students in Lithuania.立陶宛大学生中脑膜炎奈瑟菌带菌菌株的分子特征。
BMC Microbiol. 2023 Nov 17;23(1):352. doi: 10.1186/s12866-023-03111-5.
5
Meningococcal carriage in children and young adults: a cross-sectional and longitudinal study, Iceland, 2019 to 2021.2019 至 2021 年冰岛儿童和青年人群中脑膜炎奈瑟菌带菌情况:一项横断面和纵向研究。
Euro Surveill. 2023 Sep;28(39). doi: 10.2807/1560-7917.ES.2023.28.39.2300215.
6
Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA).利用全细胞改良免疫球蛋白捕获检测法(mICA)提高人源单克隆抗体的克隆效率。
Front Immunol. 2023 Jun 2;14:1184510. doi: 10.3389/fimmu.2023.1184510. eCollection 2023.
7
Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK.建模 COVID-19 和常规 MenACWY 疫苗接种对英国脑膜炎奈瑟菌传播和疾病的影响。
Epidemiol Infect. 2023 Jun 1;151:e98. doi: 10.1017/S0950268823000870.
8
Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines.脑膜炎奈瑟菌因子 H 结合蛋白:对疾病易感性、毒力和疫苗的影响。
Trends Microbiol. 2023 Aug;31(8):805-815. doi: 10.1016/j.tim.2023.02.011. Epub 2023 Mar 20.
9
Prevalence and persistence of carriage in Swedish university students.瑞典大学生携带率及持续性。
Epidemiol Infect. 2023 Feb 13;151:e25. doi: 10.1017/S0950268823000018.
10
Prevalence and Characteristics of Carriage of Among Young Israeli Adults.以色列年轻成年人中[具体内容缺失]携带情况的患病率及特征
Open Forum Infect Dis. 2022 Sep 19;9(10):ofac482. doi: 10.1093/ofid/ofac482. eCollection 2022 Oct.
流行病学趋势、全球脑膜炎球菌疫苗接种指南的转变以及支持使用破伤风蛋白结合A、C、W、Y群脑膜炎球菌疫苗的数据:一项综述
Infect Dis Ther. 2019 Sep;8(3):307-333. doi: 10.1007/s40121-019-0254-1. Epub 2019 Jul 25.
4
Changes in millennial adolescent mental health and health-related behaviours over 10 years: a population cohort comparison study.千年之交青少年心理健康和相关行为在 10 年内的变化:一项基于人群的队列比较研究。
Int J Epidemiol. 2019 Oct 1;48(5):1650-1664. doi: 10.1093/ije/dyz006.
5
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.全球脑膜炎球菌倡议会议:全球预防脑膜炎球菌病:流行病学、监测、高毒力菌株、抗生素耐药性和高危人群。
Expert Rev Vaccines. 2019 Jan;18(1):15-30. doi: 10.1080/14760584.2019.1557520. Epub 2018 Dec 27.
6
Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications.开放获取的细菌群体基因组学:BIGSdb软件、PubMLST.org网站及其应用。
Wellcome Open Res. 2018 Sep 24;3:124. doi: 10.12688/wellcomeopenres.14826.1. eCollection 2018.
7
Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.近年来世界范围内脑膜炎奈瑟菌 W 群的流行病学变化、当前的疫苗接种政策选择和未来可能的策略。
Hum Vaccin Immunother. 2019;15(2):470-480. doi: 10.1080/21645515.2018.1532248. Epub 2018 Oct 26.
8
Enter B and W: two new meningococcal vaccine programmes launched.进入百白破疫苗和白喉破伤风疫苗阶段:启动了两项新的脑膜炎球菌疫苗计划。 (注:这里原文的“B and W”推测可能是指“百白破疫苗(Diphtheria, Tetanus, Pertussis vaccine)”和“白喉破伤风疫苗(Diphtheria and Tetanus vaccine)”,常规说法是“DPT”和“DT”,翻译可能因具体背景信息不同而有差异,以上翻译仅供参考。) 不过严格按照字面意思准确翻译是:进入B和W:启动了两项新的脑膜炎球菌疫苗计划。 (因为不知道B和W具体所指,只能直接翻译)
Arch Dis Child. 2016 Jan;101(1):91-5. doi: 10.1136/archdischild-2015-308928.
9
Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.国家监测中与年龄相关的脑膜炎球菌谱系的基因组流行病学:一项观察性队列研究。
Lancet Infect Dis. 2015 Dec;15(12):1420-8. doi: 10.1016/S1473-3099(15)00267-4. Epub 2015 Oct 27.
10
Global incidence of serogroup B invasive meningococcal disease: a systematic review.全球 B 群侵袭性脑膜炎球菌病的发病率:一项系统评价。
Lancet Infect Dis. 2015 Nov;15(11):1334-46. doi: 10.1016/S1473-3099(15)00217-0. Epub 2015 Oct 6.